A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
Phase of Trial: Phase 0
Latest Information Update: 19 Sep 2017
At a glance
- Drugs Fingolimod (Primary)
- Indications Astrocytoma; Glioma
- Focus Adverse reactions
- 12 Sep 2017 Status changed from recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 24 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017.